Paxman AB (publ) (STO:PAX)

Market Cap	1.73B
Revenue (ttm)	272.09M
Net Income (ttm)	21.58M
Shares Out	21.37M
EPS (ttm)	1.12
PE Ratio	72.13
Forward PE	43.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,627
Average Volume	29,513
Open	81.00
Previous Close	81.00
Day's Range	79.20 - 81.00
52-Week Range	48.80 - 85.80
Beta	0.36
RSI	56.30
Earnings Date	Aug 20, 2025

About Paxman AB

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to utilize state-of-the-art technological advances to develop a wearable medical cooling device, and the National University Hospital of Singapore for the development of a cooling and compression system. Paxman AB (publ) was founded in 1...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 105
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: PAX

Financial Performance

In 2024, Paxman AB's revenue was 263.20 million, an increase of 19.30% compared to the previous year's 220.61 million. Earnings were 40.20 million, an increase of 382.55%.